Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2021
Alentis Therapeutics raises $67 million in Series B financing
Alentis Therapeutics announced that it raised USD 67 million in Series B financing to advance clinical trials and support drug discovery programs.
2021
PreComb Therapeutics secures seed financing
PreComb Therapeutics secured seed financing led by Kinled Austria, High-Tech Gründerfonds and FiveT Capital, with participation from other investors. The funding is intended to advance its proprietary 3D3 Technology for patient-specific drug response analysis and position the company in point-of-care solutions for patient-specific drug testing.
2020
SimScale closes €27 million Series C funding round
SimScale announced that it had closed a €27 million Series C funding round led by Insight Partners, with participation from existing investors. The company said it would use the investment to accelerate expansion of its cloud-based engineering simulation platform and grow global operations.
2019
HQS closes €2.3 million seed financing round
HQS closed a €2.3 million seed financing round with investors UVC Partners, HTGF and btov.